1. Home
  2. CYCC vs NCPL Comparison

CYCC vs NCPL Comparison

Compare CYCC & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • NCPL
  • Stock Information
  • Founded
  • CYCC 1992
  • NCPL 1984
  • Country
  • CYCC United States
  • NCPL United States
  • Employees
  • CYCC N/A
  • NCPL N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • NCPL Investment Managers
  • Sector
  • CYCC Health Care
  • NCPL Finance
  • Exchange
  • CYCC Nasdaq
  • NCPL Nasdaq
  • Market Cap
  • CYCC 3.6M
  • NCPL 3.9M
  • IPO Year
  • CYCC N/A
  • NCPL N/A
  • Fundamental
  • Price
  • CYCC $0.34
  • NCPL $2.29
  • Analyst Decision
  • CYCC Strong Buy
  • NCPL
  • Analyst Count
  • CYCC 1
  • NCPL 0
  • Target Price
  • CYCC $11.00
  • NCPL N/A
  • AVG Volume (30 Days)
  • CYCC 404.4K
  • NCPL 87.6K
  • Earning Date
  • CYCC 03-18-2025
  • NCPL 03-17-2025
  • Dividend Yield
  • CYCC N/A
  • NCPL N/A
  • EPS Growth
  • CYCC N/A
  • NCPL N/A
  • EPS
  • CYCC N/A
  • NCPL N/A
  • Revenue
  • CYCC $74,000.00
  • NCPL $1,702,723.00
  • Revenue This Year
  • CYCC N/A
  • NCPL N/A
  • Revenue Next Year
  • CYCC $88.68
  • NCPL $101.16
  • P/E Ratio
  • CYCC N/A
  • NCPL N/A
  • Revenue Growth
  • CYCC N/A
  • NCPL N/A
  • 52 Week Low
  • CYCC $0.30
  • NCPL $1.41
  • 52 Week High
  • CYCC $4.00
  • NCPL $22.82
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 46.57
  • NCPL 56.78
  • Support Level
  • CYCC $0.32
  • NCPL $2.09
  • Resistance Level
  • CYCC $0.38
  • NCPL $2.45
  • Average True Range (ATR)
  • CYCC 0.02
  • NCPL 0.13
  • MACD
  • CYCC 0.00
  • NCPL 0.01
  • Stochastic Oscillator
  • CYCC 50.00
  • NCPL 58.66

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

About NCPL Netcapital Inc.

Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.

Share on Social Networks: